We describe a simple protocol that allows the retrieval of masked or hidden intracellular antigens in cultured cells. The protocol is based on the exposure of paraformaldehyde-fied and Triton X-100-permeabilized cells to guanidine hydrochloride (GdnHCl). We used it for localization of m e r e n t Our results showed that five out of six antibodies, initially unreactive, became excellent localization tools when used in conjunction with GdnHC1. Denaturation of fiied cells with GdnHCl did not affect the overall cell architecture, antigm in BHK-21 cells by i m m~~~~f l~~r e s~n c e ~~O S C O~.
Introduction
Immunofluorescence microscopy is widely used to localize specific antigens at the cellular level. The production of specific antibodies to purified proteins, expressed gene products, or synthetic peptides is one of the most fundamental tasks in cell biology. Unfortunately, not all of the antibodies produced are applicable for localization studies, although they are reactive when used, for example, in Western blotting (8, 16, 21) .
The reason for antigenic masking is far from resolved, but in many cases it may be due to steric hindrance. The antigenic site of a protein can be masked by other proteins in protein complexes or the site may disappear when the protein assumes different conformations depending on its intracellular localization (5, 11, 24) . In situations where antigens are purified under denaturing conditions, corresponding antibodies may also be unreactive when used to analyze antigens in their native conformation. Synthetic peptides or fusion proteins are widely used to produce antibodies against chosen regions of proteins. These antibodies are frequently found to be unreactive when used in immunofluorescence microscopy, probably because the antigenic region is not exposed on the surface of the protein (16, 20) . PERANEN, RIKKONEN, against the non-structural proteins of SFV has been previously described (15J6). They were all affinitypurified according to a published procedure (15) . Polydonal antibodies (anti-El, anti-E2, and anti-spike) to the SFV structural proteins were used as reported earlier (9J9). The Golgi-specific anti-58 KD antibody was obtained from Dr. Jaa!&o S m t e (17) . The specificity ofthe rabbit IgG a&t clathrin light chains from pig brain (anti-clathrin LC) was determined by Western blotting (Periinen, unpublished data) .
The specificity of the anti-a-tubulin and anti-a-tubulin monoclonal antibodies (MAb) has been described previously (2) . The mouse MAb 67CBll is against a-actinin, and the mouse MAb lOlAA6 is against spectrin (12, 25 ). Other mouse MAb tested were anti-desmin (PD37EHll) and anti-vimentin (FV24BA6) (23). All these MAb were kindly provided by Dr. Ismo Virtanen. The mouse anti-idiotype antibody F13 was a gift from Dr. David
Immunofluorescence Microscopy. BHK-21 cells, grown on coverslips in 35-mm plastic dishes, were rinsed once with PBS (containing Ca2+ and Mg2' ) + 0.2% BSA, and were then fixed by freshly prepared 3% paraformaldehyde in PBS for 10 min at room temperature. The fixed cells were washed two times with PBS and then incubated with 20 mM glycine, pH 7.5, in PBS for 10 min. When glutaraldehyde (0.05% final concentration) was added to the fixative, we used 50 mM glycine, pH 7.5, in PBS for 20 min to block unreacted aldehyde groups. The cells were then permeabilized by incubation in 0.05% Tx-100 in PBS for 30 min at room temperature. This was followed by two washes with PBS + 0.2% BSA.
Denaturation of intracellular proteins was done by applying 50 11 of 6 N guanidine hydrochloride (GdnHC1) in 50 mM Tris-HCI, pH 7.5, to the coverslips for 10 min at room temperature. The cells on the coverslips were then rinsed three times with PBS + 0.2% BSA.
The primary antibody was diluted appropriately in PBS + 0.2% BSA and applied to the coverslips for 30 min at 37°C. Then the cells were washed four times during a period of 30 min. As secondary antibody we used either swine anti-rabbit IgG-tetramethylrhodamine isothiocyanate (TRITC) (Dako; Santa Barbara, CA) or affinity-purified goat anti-mouse IgG-fluorescein thiocyanate (FIX) (Zymed; Burlingame. CA), diluted as recommended by the manufacturers. The incubation with the secondary antibodies was for 30 min at 37'C. The coverslips were then washed four times with PBS + 0.2% BSA during 30 min and once in double-distilled HzO before they were mounted in PBS-buffered glycerol. The cells were examined by epifluorescence in an Olympus BH-2 microscope and photographed with Ilford HP5.
Results
We have recently raised antisera against selected regions of the nonstructural proteins (nsP1-nsP4) of SFV by using fusion proteins (16). These antibodies (anti-nsP1, anti-nsP2A. anti-nsP2B, anti-nsP3, and anti-nsP4) function well when used in Western blotting or in immunoprecipitation after prior denaturation of the antigens. Unfortunately, only anti-nsP2B and anti-nsP3 were able to react with corresponding antigens in paraformaldehyde-fixed, SFV-infected cells (15, 16) . In infected cells the anti-nsP3 stains modified endosomes and lysosomes termed Type I cytopathic vacuoles (CPVI), whereas anti-nsP2B recognizes nuclear nsP2 but not vacuolar nsP2 (8, 14, 15) . By pre-treating the fixed cells with 6 N GdnHCl we were able to obtain brightly staining vesicles with the anti-nsP1 antibody ( Figure lB) , whereas no staining was seen in untreated cells ( Figure 1A ). After GdnHCl treatment, anti-nsP2B gave not only the earlier observed nuclear staining ( Figure IC) but also a vacuolar staining ( Figure ID) . When anti-nsP2A was used no specific staining could be observed ( Figure 1E ). The denaturation protocol revealed vacuolar structures with this antibody ( Figure IF) . However, no nuclear staining could be demonstrated. The anti-nsP3 antibody functioned as a control for CPVI staining (14) because it was able to recognize the antigen in untreated cells ( Figure 2E ). The exposure of the cells to GdnHCl did not alter the vacuolar staining pattern of anti-nsP3, indicating that this denaturant neither altered the antigenicity of nsP3 nor grossly effected the cell architecture ( Figure 2F ). SFV-infected cells probed with anti-nsP4 showed no positive staining (Figure lG) , in contrast to GdnHCIdenatured cells, in which it stained intracellular vesicles ( Figure  1H ). Therefore, it seems that all of the ns proteins are localized to similar vesicles and vacuolar structures. Vacuolar staining by GdnHCl was not detected with (a) uninfected cells, (b) pre-immune sera, or (c) secondary antisera alone (not shown). The results showed that all nsP antibodies that were initially considered unreactive turned out to be useful after pre-treatment of fixed SFV-infected cells with GdnHC1.
To see if this protocol could also be applied to other antibodies, we tested a set of both polyclonal and monoclonal antibodies. After screening 17 different antibodies we found three MAb, anti-aactinin (12) (Figure lI ), anti-spectrin (25) ( Figure lK) , and antidesmin (23) (not shown), that showed no staining when applied to paraformaldehyde-fixed BHK cells. When cells were denatured, the anti-a-actinin antibody gave a bright typical fibrillar staining, indicating that the antigenic site was unmasked ( Figure 1J ). This treatment was likewise successful for the anti-spectrin antibody, which now showed a membrane type of staining ( Figure 1L ). In contrast, GdnHCl could not retrieve the antigenic site for the antidesmin MAb, which gave a positive signal in cells fixed with acetone/methanol (not shown).
Next, we wanted to study if the denaturation protocol has a negative effect on the overall cell architecture. To do this we used antibodies that are localized to different cell compartments. The rough endoplasmic reticulum (RER) was monitored by using the tsl mutant of SFV, which has a mutation in the E3 protein that hinders the viral envelope proteins from leaving the RER at the restrictive temperature (19). Three different antibodies against the envelope proteins (anti-El, anti-E2, and anti-spike) were used to stain the RER. We were not able to detect any morphological alterations of the RER after GdnHCl treatment ( Figure 2B ) with these antibodies, as compared with untreated cells (Figure 2A ). The structure of the Golgi complex was studied using a cis-Golgi marker, anti-58 KD antibody (13). As for the RER, no changes of the Golgi complex could be observed after denaturation ( Figures 2C and 2D ). This was also true for the enveloped proteins of tsl which are localized to the Golgi complex after shifting the cells to the permissive temperature (not shown). The morphology of the endosomes and lysosomes, as monitored by the anti-nsP3 antibody (Figures 2E and  2F ), was not altered by this procedure. We also used the low molecular weight endocytic fluid-phase marker Lucifer yellow (LY). From these experiments it could be seen that the LY staining pattern was similar in both the absence and the presence of GdnHCl ( Figures  2G and 2H ). However, the fluorescent staining was much less intense in cells treated with GdnHCl ( Figure 2H ). The nucleus also appeared quite normal after denaturation, as shown for the anti-nsP2B ( Figure IC ). Other antibodies that gave identical staining for both GdnHC1-treated and untreated BHK cells were a mono-
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anti-spectrin 21 and 2J ) and a monoclonal antiidiotype F13 antibody (22) (not shown). Furthermore, this procedure did not result in any increased background staining. Conclusively, it can be said that the cell morphology is not greatly altered after GdnHCl treatment, as assayed by immunofluorescence microscopy. GdnHCl permeabilizes membranes without prior Triton X-100 treatment (see below). In some cases this property can be disadvantageous, e.g., when surface antigens on the plasma membrane are to be distinguished from intracellular antigens in double labeling studies. Nevertheless, this problem can be overcome by refixing the cells after the first round of staining, before denaturation. In Figure 2 the E1 proteins on the surface of SFV-infected cells were detected by anti-El antibodies followed by TRITC-conjugated antibody. These antibodies were immobilized by 3% paraformaldehyde. Thereafter the intracellular a-actinin antigen was revealed by GdnHCl denaturation without Tx-100 pre-treatment, followed by anti-a-actinin antibody and FITC-conjugated antibody ( Figures  2K and 2L) . The results showed that only surface El are stained and no intracellular El, although inuacellular a-actinin was revealed.
We found three antibodies that failed to recognize their specific antigens after exposure of the cells to GdnHCI. These antibodies were anti-a-tubulin (2), anti-0-tubulin (2) and anti-clathrin-LC. In cases where a very weak a-tubulin ( Figures 3A and 3B ) or 0-tubulin (not shown) staining was detected, the microtubules seemed to be disrupted. We also tested other anti-tubulin antibodies, but the result was always the same (not shown). The anticlathrin-LC antibody showed both a punctate staining at the plasma membrane and a Golgi-specific staining (Figure 31 ). Both of these patterns disappeared after denaturation, and only an altered faint staining remained ( Figure 3J ).
Because the microtubules seemed to collapse after denaturation we reasoned that the inclusion of low amounts (0.05% final) of glutaraldehyde in the paraformaldehyde fixative could stabilize the microtubules. First, by addition of glutaraldehyde we were able to completely inhibit the disruption of the microtubules ( Figure  3D ), and we could no longer observe any differences between GdnHCI-treated and untreated cells ( Figures 3D and 3C) . Second, the inclusion of glutaraldehyde clearly gave better microtubule staining when compared with cells fixed with paraformaldehyde alone, even without GdnHCl treatment. Next, we wanted to find out if GdnHCl was still able to retrieve antigenic sites in cells incubated in fixatives containing low amounts of glutaraldehyde. For this purpose we used the anti-a-actinin and anti-spectrin antibodies, which do not recognize corresponding antigenic sites without denaturation. As shown in Figure 3F , GdnHCl treatment resulted in antigenic retrieval of a-actinin, despite the inclusion of glutaraldehyde in the fixative. This was also observed for anti-spectrin ( Figures 3G  and 3H) .
The inclusion of glutaraldehyde in the fixative could not preserve the clathrin staining (not shown). Furthermore, glutaraldehyde by itself seemed to mask the antigenic sites of clathrin light chains to the anti-clathrin-LC antibodies (not shown). However, by refixing the cells after application of the anti-clathrin-LC and secondary antibodies (TRITC), the clathrin-specific staining pattern sustained GdnHCl treatment ( Figure 3L ).
Discussion
To achieve good results in both immunohistochemistry and immunocytochemistry, experimental conditions should be sought that promote adequate preservation of tissue and cell structure while maintaining the antigenicity of the antigen studied. However, it is not always possible to fulfill both of these conditions simultaneously. Loss of antigenicity is a well-known problem in both immunohistochemistry and immunocytochemistry. Therefore, it is not uncommon for many otherwise reactive antibodies to be unreactive when used in immunofluorescence microscopy. We were confronted by this problem while studying the nonstructural proteins of SFV with the help of polyclonal antibodies made against fusion proteins containing selected regions of the ns proteins.
Although all of the antibodies against the SFV ns proteins reacted with corresponding denatured antigen, only a few of them were reactive in immunofluorescence microscopy. We initially tried different fiitives such as acetone, methanol, and paraformaldehyde, but none of them gave positive results (16; and Perben, unpublished observation). Taraboulus et al. (20) used GdnHCl to localize intracellular prion protein PrPSC. These authors showed that their antibodies reacted well only with denatured cellular prion protein PrPsc, and that the antibodies could not be used for localization studies. However, immunolocalization became possible when the fixed cells were denatured by GdnHC1. More importantly, we demonstrate here that this protocol is not restricted to antibodies against PrP but that it has wider applications, because it allows the retrieval of quite different antigens. We also examined possible negative effects of GdnHCl on the cell structure and on antigenic sites that normally are reactive. Moreover, the protocol was modified to achieve a better preservation of some antigens.
Using this method, we were able to show for the first time that all of the SFV ns proteins are localized to similar vesicles and vacuoles, most likely corresponding to the CPVIs. This is in good agreement with protein cross-linking studies which have demonstrated that these proteins form multiprotein complexes (1, 8, 13) . The mechanisms responsible for the retrieval of antigenic sites by GdnHCl are not known, but the results obtained for the anti-nsP antibodies might give some information. First, we know that most of the anti-nsP antibodies react only with denatured antigens and that the antibodies are made against selected regions of corresponding proteins. The anti-nsPZB, which was made against a C-terminal fragment of nsP2 (16). recognized predominantly nuclear nsP2 (15), while GdnHCl revealed also cytoplasmic nsP2 on vacuolar structures. In contrast, anti-nsP2A made against an N-terminal region of nsP2 was totally unreactive, becoming reactive after GdnHCl treatment. However, anti-nsP2A could stain only cytoplasmic vacuoles, but not nuclear nsP2, despite the use of GdnHC1. Therefore both the C-and N-terminus were unmasked on cytoplasmic vacuoles, whereas the N-terminus was hidden in the nucleus even in the presence of GdnHC1. This suggests that the nuclear N-terminus interacts with some component in the nucleus that masks the antigenic site. Therefore, it seems unlikely that GdnHCl could denature the nsP2 protein into random configurations and thereby expose almost any hidden antigenic sites. Rather, GdnHCl might open protein domains or protein complexes at sites that are not crosslinked by paraformaldehyde, thereby giving access to the antibody in question. In addition, proteins not cross-linked by paraformaldehyde could be extracted, making it easier for the antibody to find its target. Furthermore, the hidden nuclear antigenic site of nsP2 indicates that there will be situations in which GdnHCl treatment cannot retrieve antigenic sites. This seemed to be the case for a monoclonal anti-desmin antibody, whose antigenic site was lost due to paraformaldehyde ueatment and could not be retrieved by GdnHC1. We found two intracellular structures that lost their antigenicity after GdnHCl treatment. One of them was the microtubules, which disappeared independently of the antibody used. The low background staining that remained after GdnHCl indicated that the microtubules were disrupted and probably washed away during the immunofluorescence staining protocol. This was confirmed by the fact that GdnHCl was not able to destroy the microtubule structure when the cells had been fixed with paraformaldehyde containing low amounts of glutaraldehyde. From this it is clear that the more potent cross-linking properties of glutaraldehyde better preserve protein cell structures in the presence of the denaturing agent. It should be noted that low amounts of glutaraldehyde do not destroy the antigenic retrieval property of GdnHC1. Therefore, it is advisable to try the inclusion of glutaraldehyde in cases where negative results have been obtained for paraformaldehyde-fixed cells. The clathrin staining pattern was also lost due to GdnHC1, but in contrast to the microtubules this pattern could not be preserved by the inclusion of glutaraldehyde. However, in this case we favor the idea that GdnHCl actually masked the antigenic sites of the clathrin light chains, rather than extracted the antigens from the cell. First, we know that our anti-clathrin-LC antibody does not stain properly when the fixation with paraformaldehyde is done at 39°C and when glutaraldehyde is included in the fixative, indicating that antigenic sites recognized by this antibody are very sensitive to alterations in the physochemical conditions (Peranen, unpublished observations) . Second, GdnHCl treatment was not able to alter the normal clathrin staining pattern when corresponding antibodies were fixed before the GdnHCl treatment.
The present protocol did not seem to affect the cell architecture, except for the microtubules, when monitored by different organelle-specific antibodies. Furthermore, we observed no detached cells or elevated background staining. GdnHCl permeabilizes cells, which means that it is actually unnecessary to use Tx-100 for permeabilization. The permeabilizing effect of GdnHCl implies that this method is difficult to use for selective labeling of plasma membrane proteins in double labeling studies. This is not a problem if the plasma membrane antigen is exposed, because the plasma membrane protein can be stained and refixed before application of GdnHC1. The antigen to be unmasked is then revealed by GdnHC1.
Despite the few drawbacks, the method has many advantages. First, the retrieval of antigenic sites seems to be applicable to quite different antigens. Second, the cell structure is well preserved. No protease treatment is needed, as in immunohistochemical procedures. In fact, protease treatment results both in poor cell architecture and in loss of antigenicity when used to study cellular components in single cells (20; and Peranen, unpublished observations). Third, the method is rapid and simple. Furthermore, the inclusion of low amounts of glutaraldehyde widens the applications of this protocol. We have used this protocol with success in double labeling studies for other cells than BHK (not shown), and it is suitable both for monoclonal and polyclonal antibodies. We believe that this method will extend the usefulness of many antibodies. 43:199, 1990 
